Richard Morris
2023
In 2023, Richard Morris earned a total compensation of $1.7M as Current Chief Financial Officer at Eleven Biotherapeutics.
Compensation breakdown
| Bonus | $183,064 |
|---|---|
| Option Awards | $1,077,948 |
| Salary | $384,302 |
| Other | $17,487 |
| Total | $1,662,801 |
Morris received $1.1M in option awards, accounting for 65% of the total pay in 2023.
Morris also received $183.1K in bonus, $384.3K in salary and $17.5K in other compensation.
Rankings
In 2023, Richard Morris' compensation ranked 687th out of 3,006 executives tracked by ExecPay. In other words, Morris earned more than 77.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 687 out of 3,006 | 77th |
Division Manufacturing | 387 out of 1,650 | 77th |
Major group Chemicals And Allied Products | 264 out of 918 | 71st |
Industry group Drugs | 260 out of 881 | 71st |
Industry Pharmaceutical Preparations | 166 out of 637 | 74th |
Source: SEC filing on April 29, 2024.
Morris' colleagues
We found five more compensation records of executives who worked with Richard Morris at Eleven Biotherapeutics in 2023.
2023
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
2023
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
2023
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
2023
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
2023
Mark Sullivan
Eleven Biotherapeutics